Focal segmental glomerulosclerosis associated with idiopathic myelofibrosis

Renal Failure

Volumn 32, Issue 2, 2010, Pages 273-276

  Kaygusuz, Isik ^a   Koc, Mehmet ^a   Arikan, Hakki ^a   Adiguzel, Cafer ^a   Cakalagaoglu, Fulya ^a   Tuglular, Tulin F ^a   Akoglu, Emel ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Cyclosporine; Focal segmental glomerulosclerosis; Myelofibrosis; Nephrotic syndrome

Indexed keywords

CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYUREA; METHYLPREDNISOLONE; PREDNISOLONE; STEROID;

ADULT; ARTICLE; ASCITES; BLOOD SMEAR; BONE MARROW BIOPSY; CASE REPORT; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DYSPNEA; ECHOGRAPHY; FOCAL GLOMERULOSCLEROSIS; GENERALIZED EDEMA; HEMATURIA; HEMODIALYSIS; HEPATOMEGALY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MYELOID METAPLASIA; PHYSICAL EXAMINATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEINURIA; SPLENOMEGALY; URINALYSIS;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; MIDDLE AGED; PRIMARY MYELOFIBROSIS;

EID: 77749297968     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860220903573286     Document Type: Article

References (21)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
2. Mesa R, Barosi G, Cervantes F. Myelofibrosis with myeloid metaplasia: Disease overview and non-transplant treatment options. Best Practice & Research Clinical Hematology. 2006;19:495-517.
3. Caijo Y, Almange C, Boutin J, Leblay R, Guerin D. Renal lesions in myelofibrosis. Sem Hop. 979;55:1271-1274.
4. Ferhanoglu B, Erzin Y, Baslar Z, Tuzuner HA. Secondary amyloidosis in the course of idiopathic myelofibrosis. Leukemia Research. 1997;21:897-898.
5. Oesterling JE, Keating JP, Leroy AJ, et al. Idiopathic myelofibrosis with myeloid metaplasia involving the renal pelvis, ureters and bladder. J Urol. 1992;147:1360.
6. Liu TT, Chen JB, Chen WJ, Kuo CY, Lee CT. Idiopathic myelofibrosis associated with renal extramedullary hemato-poiesis and nephrotic syndrome: Case report. Chang Gung Med J. 2000;23:169-174.
7. Pamuk ON, Pamuk GE, Altiparmak MR, Sonsuz A, Solakoglu S, Kilicaslan I. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Leuk Lymphoma. 2002;43: 661-663.
8. Chan KW, Ho CP. Amyloidosis complicating idiopathic myelofibrosis. Am J Kidney Dis. 1999;34:E27.
9. Kwak H, Lee J. CT findings of extramedullary hematopoiesis in the thorax, liver and kidneys in a patient with idiopathic myelofibrosis. J Korean Med Sci. 2000;15:460-462.
10. Cameron JS. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant. 2003;18 (Suppl. 6):45-51.
11. Perazella MA, Buller GK. Nephrotic syndrome associated with agnogenic myeloid metaplasia. Am J Nephrol. 1994;14: 223-225.
12. Gordon BR, Coleman M, Kohen P. Immunologic abnormalities in myelofibrosis with activation of the complement system. Blood. 1981;58:904-910.
13. Vellenga E, Mulder N. A study of the cellular and humoral immune response in patients with myelofibrosis. Clin Lab Heamatol. 1982;4:307-316.
14. Centenara E, Guarnone R, Ippoliti G, Barosi G. Cyclosporine-A in severe refractory anemia of myelofibrosis with myeloid metaplasia: A preliminary report. Hematologica. 1998;83: 622-626.
15. Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med. 1996;334:878-883.
16. Schnuelle P, Waldherr R, Lehmann KJ, et al. Idiopathic myelofibrosis with Extramedullary hematopoiesis in the kidneys. Clin Nephrology. 1999;52:256-262.
17. Abboud HE. Role of platelet-derived growth factor in renal injury. Annu Rev Physiol. 1995;57:297-309.
18. Sterzel RB, Hartner A, Schlotzer-Schrehardt U, et al. Elastic fiber proteins in the glomerular mesangium in vivo and in cell culture. Kidney Int. 2000;58:588-602.
19. Daniel V, Trautmann Y, Konrad M, Nayir A, Schärer K. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol. 1997;47:289-297.
20. Cattran DC, Appel GB, Hebert LA, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int. 1999;56:2220-2226.
21. Pietrasanta D, Clavio M, Vallebella E, Beltrami G, Cavaliere M, Gobbi M. Long-lasting effect of cyclosporine-A on anemia associated with idiopathic myelofibrosis. Hematologica. 1997;82:458-459